BREAST CANCER

This adverse event was reported 93292 times

These drugs are most commonly taken by patients reporting BREAST CANCER:

# Drug Count
0 RANITIDINE 24854
1 ESTROGENS, CONJUGATED 9643
2 CONJUGATED ESTROGENS 9624
3 MEDROXYPROGESTERONE ACETATE 8169
4 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 7889
5 RANITIDINE HYDROCHLORIDE 7734
6 ETANERCEPT 2185
7 METHOTREXATE SODIUM 1992
8 ESTRADIOL 1881
9 LETROZOLE 1875
See all common drugs associated with BREAST CANCER

BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 109 0.1584
1 Estrogen [EPC] 12719 0.0680
2 Provitamin D2 Compound [EPC] 1220 0.0410
3 Aromatase Inhibitor [EPC] 3287 0.0289
4 Estrogen Receptor Antagonist [EPC] 965 0.0238
5 Progesterone [EPC] 467 0.0197
6 Guanylate Cyclase-C Agonist [EPC] 39 0.0188
7 Endoglycosidase [EPC] 33 0.0178
8 Interleukin-17A Antagonist [EPC] 618 0.0166
9 HER2/neu Receptor Antagonist [EPC] 747 0.0100
See all drug classes enriched for association with BREAST CANCER